Advanced Health Intelligence Ltd (AHI) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED 2024
What happened to Advanced Health Intelligence Ltd (AHI) stock?
Advanced Health Intelligence Ltd (AHI) no longer trades on public markets. It was delisted in February 2024. The figures below are historical and are not a current quote.
Beta 1.61: the stock has moved about 61% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Advanced Health Intelligence Ltd (AHI). Advanced Health Intelligence Ltd specializes in mobile application and technology development, focusing on body dimensioning and health risk assessment via smartphone technology. The company targets the mobile health, telehealth, insurance, and wellness sectors. Sector: Technology.
Last analyzed: Mar 16, 2026Analyst Coverage for AHI: AHI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AHI against Technology peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Dated analysis: the newest financial statements on file are 27 months old (Jun 1, 2024), so the figures and score below describe that period, not today.
AHI: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Advanced Health Intelligence Ltd (AHI) Technology Profile & Competitive Position
Advanced Health Intelligence Ltd (AHI) is an Australian technology company specializing in mobile health solutions, offering patented BodyScan, FaceScan, and DermaScan technologies for body dimensioning, vital sign measurement, and dermatological risk assessment. AHI serves the mobile health, telehealth, insurance, and wellness sectors, operating internationally from its base in South Perth.
What Is the Investment Thesis for AHI?
The company's focus on non-invasive health assessment via smartphone positions it favorably in the expanding telehealth and digital health markets. AHI's ability to serve multiple sectors, including insurance, fitness, and apparel, diversifies its revenue streams and reduces reliance on any single market. Key to AHI's success will be its ability to secure strategic partnerships and integrate its technologies into established platforms. The company's negative profit and gross margins of -154.7% and -138.9% respectively, highlight the need for improved financial performance. AHI's high beta of 1.61 indicates higher volatility compared to the market. Successful commercialization and market penetration are crucial for driving long-term value.
Based on FMP financials and quantitative analysis
AHI Key Highlights
Market capitalization of $0.35 billion reflects investor valuation of AHI's technology and market potential.
- P/E ratio of -5.65 indicates that the company is currently not profitable, requiring careful monitoring of future earnings.
- Negative profit margin of -154.7% highlights the need for improved cost management and revenue generation.
- Negative gross margin of -138.9% suggests challenges in pricing and cost of goods sold, requiring strategic adjustments.
- Beta of 1.61 indicates higher volatility compared to the market, reflecting the speculative nature of the stock.
Who Are AHI's Competitors?
AHI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CIH China Index Holdings Limited | $0.95 | 0.00% | $85.7M | — |
| CTK CooTek (Cayman) Inc. | $0.91 | 0.00% | — | |
| CYBNY Cyber Security 1 AB (publ) | $0.07 | 0.00% | $11.6M | — |
| DIDI DiDi Global Inc. | $2.29 | 0.00% | — | |
| MTBL Moatable, Inc. | $0.45 | -30.60% | $10.4M | — |
| SAP SAP SE | $205.95 | -1.53% | $240B | 845-pillar |
| CRM Salesforce, Inc. | $246.36 | +1.38% | $202B | 745-pillar |
| SHOP Shopify Inc. | $131.59 | +3.95% | $171B | 735-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AHI's Key Strengths?
Patented BodyScan technology provides a unique competitive advantage.
- Proprietary FaceScan and DermaScan technologies offer specialized health assessment capabilities.
- Serves multiple sectors, including mobile health, telehealth, insurance, and apparel.
- Established partnerships with key players in the mobile health and telehealth sectors.
What Are AHI's Weaknesses?
Negative profit and gross margins indicate financial challenges.
- High beta suggests higher volatility compared to the market.
- Limited brand recognition compared to larger competitors.
- Reliance on technology licensing and partnerships for revenue generation.
What Could Drive AHI Stock Higher?
Strategic partnerships with telehealth providers to integrate BodyScan and FaceScan technologies.
- Expansion into new geographic markets, particularly in emerging economies.
- Launch of new features and functionalities for BodyScan, FaceScan, and DermaScan technologies by Q4 2026.
- Increasing adoption of mobile health solutions by insurance companies.
- Growing consumer awareness of the benefits of personalized health monitoring.
What Are the Key Risks for AHI?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger, more established players in the mobile health market.
- Regulatory hurdles and data privacy concerns related to health data collection and usage.
- Technological obsolescence and the need for continuous innovation.
- Negative profit and gross margins indicate financial challenges.
- Economic downturns and reduced consumer spending on discretionary health and wellness products.
What Are the Growth Opportunities for AHI?
- Expansion into the telehealth market presents a significant growth opportunity for AHI. The telehealth market is projected to reach $550 billion by 2027, driven by increasing demand for remote healthcare services. AHI's BodyScan and FaceScan technologies can be integrated into telehealth platforms to provide remote health assessments, enabling healthcare providers to monitor patients' health remotely and provide timely interventions. This expansion requires strategic partnerships with telehealth providers and healthcare organizations.
- Penetration of the life and health insurance sector offers substantial growth potential. Insurance companies are increasingly using digital health solutions to assess risk, personalize premiums, and improve customer engagement. AHI's technologies can provide insurers with valuable data on policyholders' health status, enabling them to offer tailored insurance products and incentivize healthy behaviors. This opportunity requires collaboration with insurance companies and demonstration of the accuracy and reliability of AHI's technologies.
- Growth in the fitness and wellness market provides another avenue for expansion. Consumers are increasingly using mobile apps and wearable devices to track their fitness and wellness goals. AHI's BodyScan technology can be integrated into fitness apps to provide users with detailed body composition analysis, helping them to track their progress and optimize their training regimens. This requires partnerships with fitness app developers and wearable device manufacturers.
- Entering the consumer apparel sector offers a unique growth opportunity for AHI. The company's BodyScan technology can be used to provide personalized clothing recommendations, ensuring a better fit and reducing returns. This requires collaboration with apparel retailers and online marketplaces to integrate AHI's technology into their platforms. The market for personalized apparel is growing, driven by increasing demand for customized products and improved online shopping experiences.
- International expansion, particularly into emerging markets, presents a significant growth opportunity. Many emerging markets lack access to traditional healthcare infrastructure, making mobile health solutions particularly valuable. AHI's technologies can provide affordable and accessible health assessments to underserved populations, improving health outcomes and reducing healthcare costs. This requires strategic partnerships with local healthcare providers and government agencies.
What Are AHI's Competitive Advantages?
- Patented BodyScan technology provides a unique competitive advantage.
- Proprietary FaceScan and DermaScan technologies offer specialized health assessment capabilities.
- Established partnerships with key players in the mobile health and telehealth sectors.
- Integration of technologies into existing mobile applications and platforms.
- First-mover advantage in the mobile health assessment market.
What Does AHI Do?
Advanced Health Intelligence Ltd, formerly known as MyFiziq Limited, was incorporated in 2014 and is based in South Perth, Australia. The company operates as a mobile application and technology development firm, focusing on innovative solutions for health assessment and monitoring. AHI's core product is BodyScan, a patented technology that allows users to measure and assess their body dimensions using a smartphone. This technology provides detailed body composition analysis, which is valuable for various applications, including fitness, wellness, and apparel sizing. In addition to BodyScan, AHI offers FaceScan, a technology that measures vital signs and assesses risks associated with cardiovascular disease, heart attack, and stroke. This non-invasive method uses facial scanning to detect subtle indicators of health risks, providing users with early warnings and insights into their cardiovascular health. The company also provides DermaScan, a dermatological scanner that analyzes skin conditions and identifies potential dermatological issues. AHI serves a diverse range of sectors, including mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel. By providing accurate and accessible health data through mobile devices, AHI aims to empower individuals to take control of their health and well-being. The company's technologies are designed to be easily integrated into existing mobile applications and platforms, making them accessible to a wide audience. AHI's evolution from MyFiziq to Advanced Health Intelligence reflects its commitment to expanding its technological capabilities and addressing a broader range of health-related applications.
What Products and Services Does AHI Offer?
- Develops and patents BodyScan technology for body dimensioning using smartphones.
- Provides FaceScan technology for measuring vital signs and assessing cardiovascular risks.
- Offers DermaScan, a dermatological scanner for analyzing skin conditions.
- Serves mobile health and telehealth sectors with remote health assessment tools.
- Caters to life and health insurance companies for risk assessment and personalized premiums.
- Supports the fitness and wellness industry with body composition analysis for consumers.
- Partners with consumer apparel companies for personalized clothing recommendations.
How Does AHI Make Money?
- Technology licensing to mobile health and telehealth providers.
- Subscription-based access to BodyScan, FaceScan, and DermaScan technologies.
- Partnerships with insurance companies for risk assessment services.
- Integration of BodyScan into fitness apps and wearable devices.
- Collaboration with apparel retailers for personalized clothing recommendations.
What Industry Does AHI Operate In?
Advanced Health Intelligence operates within the rapidly evolving mobile health (mHealth) market, which is experiencing significant growth due to increasing smartphone penetration and rising healthcare costs. The industry is characterized by intense competition, with numerous companies offering digital health solutions. AHI differentiates itself through its patented BodyScan, FaceScan, and DermaScan technologies, which provide unique and non-invasive health assessment capabilities. The company's success depends on its ability to effectively compete with larger, more established players and capitalize on the growing demand for accessible and personalized healthcare solutions.
Who Are AHI's Key Customers?
- Mobile health and telehealth providers seeking remote health assessment tools.
- Life and health insurance companies requiring risk assessment and personalized premiums.
- Fitness and wellness companies offering body composition analysis to consumers.
- Consumer apparel companies aiming to provide personalized clothing recommendations.
- Individual consumers interested in tracking their health and fitness.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 16 days old
- ● Latest filing 803 days ago
- ● No analyst coverage
- ● Reported in AUD, converted to USD
Company Profile
Advanced Health Intelligence Ltd operates in the Software - Application industry within the Technology sector. It is headquartered in South Perth, AU. The company is led by CEO Scott Montgomery. AHI has traded publicly since 2021.
Key Financial Metrics
Return on assets is -27.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -19.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.06 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -17.7%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Advanced Health Intelligence Ltd's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 13.08 places it in the safe zone, indicating low near-term bankruptcy risk.
Earnings Track Record
Advanced Health Intelligence Ltd has beaten Wall Street's EPS estimate in 3 of its last 5 reported quarters — more hits than misses. Reported results have landed about 129.0% below estimates on average.
Forward Outlook
Wall Street analysts project Advanced Health Intelligence Ltd revenue of about $59.4M for fiscal 2026, with EPS near $0.00.
Insider Activity
The most recent 6 insider filings for Advanced Health Intelligence Ltd break down as 0 sales and 6 purchases. On net that is roughly 30K shares acquired (about $99K) — insiders putting money in tends to read as conviction.
AHI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Patented BodyScan technology provides a unique competitive advantage.
- Proprietary FaceScan and DermaScan technologies offer specialized health assessment capabilities.
- Serves multiple sectors, including mobile health, telehealth, insurance, and apparel.
- Established partnerships with key players in the mobile health and telehealth sectors.
Bear Case
- Negative profit and gross margins indicate financial challenges.
- High beta suggests higher volatility compared to the market.
- Limited brand recognition compared to larger competitors.
- Reliance on technology licensing and partnerships for revenue generation.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 FY2024 | $176,450.474 | $3M | $0.37 |
Q4 FY2024 · filed 30 Jun 2024 · SEC EDGAR →
Based on FMP financials and quantitative analysis · Converted to USD from AUD at today's rate
AHI Latest News
-
Eariler: AHI Received Delisting Notification From Nasdaq For Equity Deficiency, Plans To Appeal And Address $1.15M Shortfall With Oakley Capital's $1.96M Placement And US Shelf Offering
benzinga · May 10, 2024
-
Earlier: Kalibra Intentional Health Application Launched With AHI Integrated Biometric Screening
benzinga · May 10, 2024
-
UAE-based E-Script Medicine Management Company Pharmak Direct And AHI Extend Master Services Agreement
benzinga · Apr 14, 2024
-
Why Motus GI Holdings Shares Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket
benzinga · Dec 19, 2023
Latest News
Eariler: AHI Received Delisting Notification From Nasdaq For Equity Deficiency, Plans To Appeal And Address $1.15M Shortfall With Oakley Capital's $1.96M Placement And US Shelf Offering
Earlier: Kalibra Intentional Health Application Launched With AHI Integrated Biometric Screening
UAE-based E-Script Medicine Management Company Pharmak Direct And AHI Extend Master Services Agreement
Why Motus GI Holdings Shares Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket
Leadership: Scott Montgomery
CEO
Scott Montgomery serves as the CEO of Advanced Health Intelligence Ltd, leading a team of 32 employees. His background includes extensive experience in technology and business development, with a focus on driving innovation and growth. Prior to joining AHI, Montgomery held leadership positions in various technology companies, where he was responsible for developing and executing strategic initiatives. His expertise lies in identifying market opportunities, building strategic partnerships, and scaling technology businesses.
Track Record: Under Scott Montgomery's leadership, Advanced Health Intelligence Ltd has focused on expanding its technology portfolio and market reach. Key achievements include securing patents for BodyScan, FaceScan, and DermaScan technologies, as well as establishing partnerships with key players in the mobile health and telehealth sectors. Montgomery has also overseen the company's transition to Advanced Health Intelligence, reflecting its commitment to expanding its technological capabilities and addressing a broader range of health-related applications.
Advanced Health Intelligence Ltd ADR Information Sponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. For AHI, as an ADR, it allows U.S. investors to invest in the Australian-based Advanced Health Intelligence Ltd without the complexities of cross-border transactions. The ADR represents a specific number of AHI's ordinary shares held by a depositary bank.
- Home Market Ticker: Australian Securities Exchange (ASX), Australia
- ADR Level: 2
- ADR Ratio: 1:1
AHI Technology Stock FAQ
What happened to Advanced Health Intelligence Ltd (AHI) stock?
Advanced Health Intelligence Ltd (AHI) no longer trades on public markets. It was delisted in February 2024. The figures below are historical and are not a current quote.
Can I still buy AHI shares?
No. AHI stopped trading on public markets in February 2024, so the shares are not available through a broker. Anything you see quoted for AHI elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before AHI stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Advanced Health Intelligence Ltd. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Advanced Health Intelligence Ltd do?
Advanced Health Intelligence Ltd (AHI) is a technology company that develops and patents mobile application technologies focused on health assessment and monitoring.
What do analysts say about AHI stock?
Analyst coverage for Advanced Health Intelligence Ltd (AHI) is still emerging, reflecting its relatively small market capitalization and recent focus on commercializing its technologies.
What are the main risks for AHI?
Advanced Health Intelligence Ltd (AHI) faces several risks, including intense competition from larger, more established players in the mobile health market.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data may be subject to change.
- Analyst opinions may vary.
- Investment decisions should be based on individual risk tolerance and due diligence.